Beaumont Capital Management’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,006
Closed -$5.72K 69
2024
Q4
$5.72K Buy
+11,006
New +$5.72K ﹤0.01% 49